Lyka Labs Approves Divestment Of 100% Stake In Lyka BDR

Revenue Growth, Margins Ease PAT at Rs 2.0 Cr in Q1 FY27 (consolidated), +105.6% YoY. Revenue at Rs 42.3 Cr in Q1 FY27 (consolidated), +28.1% YoY. EBITDA at Rs 5.0 Cr, +15.0% YoY. EBITDA margin at 11.7% vs 13.1%. Board approved the proposed divestment of 100% stake in subsidiary Lyka BDR International; sale terms and completion details are pending. Auditors issued an unqualified conclusion.